June 1, 2017 — Northwell Health recently announced a new partnership agreement with Peerbridge Health Inc., to explore the future of remote medical monitoring. Peerbridge technology enables remote patient monitoring through multiple on-body wireless sensors.
To better understand the potential of this partnership, Peerbridge Health and Northwell conducted a clinical trial to measure the performance of the company’s flagship product, the Peerbridge Cor, a compact, lightweight, multi-channel electrocardiogram (ECG) monitor. To ensure efficacy, the Peerbridge Cor was compared to other cardiovascular monitors in a clinical trial.
“The trial demonstrated this technology was superior to the current Holter monitor standard,” said Nicholas Skipitaris, M.D., chief of electrophysiology at Lenox Hill Hospital in New York City. “Not only did the Peerbridge Cor deliver excellent, multi-channel, analyzable data, but it delivered less motion artifact and fewer false positives, despite our patient’s active New York lifestyle.”
The American Heart Association reports cardiovascular disease and stroke as the top two killers of American adults. Cardiovascular monitoring, both inside and outside medical environments, is critical for diagnosis, proper treatment and improved outcomes.
According to the U.S. Center for Disease Control & Prevention Foundation, annual direct medical costs associated with cardiovascular diseases are projected to rise to more than $818 billion by 2030. To get ahead of the growth in patient demand, an increasing number of providers are looking for more efficient monitoring to improve treatment and deliver better outcomes, which also has the potential to significantly reduce expenses.
For more information: www.peerbridgehealth.com
August 15, 2024 
